Fact CheckerSign in

NCT05844384Recruiting

Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial

Source: ClinicalTrials.gov · Last updated 6 May 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This randomized, single-masked, crossover, non-inferiority trial aims to evaluate the safety and efficacy of Nanodropper-mediated microdrops of ocular hypotensive topical treatments (experimental intervention) compared to standard drops of the same medication(s) (active comparator) in Wilford Hall Ambulatory Surgical Center (WHASC) primary open-angle glaucoma (POAG) and ocular hypertension (OHTN) patients.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
30 (estimated)
First submitted
14 Feb 2023
Start date
17 Mar 2022
Primary completion date
17 Mar 2024
Lead sponsor
59th Medical Wing
NCT number
NCT05844384

What you commit to

  • Study type: Interventional
  • Planned participants: 30
  • From 17 Mar 2022 to the primary completion date, 17 Mar 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Using more than 2 IOP-lowering medications.
  • IOP-lowering surgical interventions or lasers except for SLT. SLT may have been completed 6+ months prior to study start date.

Other illness

  • Glaucoma not of the POAG or OHTN variety or other retinal diseases.
  • Progression of disease within the preceding 1 year (IOP elevation, optic disc cupping, visual field changes).

Who the study is looking for

  • POAG/OHTN patients above the age of 18 years.
  • On a maximum of 2 IOP lowering medications.
  • Stable disease without progression in IOP, optic disc cupping, RNFL changes, and visual field changes within the previous 1 year.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Wilford Hall Ambulatory Surgical Center
Coordinator of this site? Confirm its status
Lackland Air Force BaseUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.